Use of an autologous leucocyte and platelet-rich fibrin patch on hard-to-heal DFUs: A pilot study

Journal of Wound Care

Volumn 24, Issue 4, 2015, Pages 172-178

  Londahl M ^a,b   Tarnow, L ^c,d,e   Karlsmark, T ^f   Lundquist, R ^g   Nielsen, A M ^h   Michelsen, M ⁱ   Nilsson, A ^j   Zakrzewski, M ^k   Jorgensen B ^f  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c STENO DIABETES CENTER   (Denmark)

^d HILLERØD HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f BISPEBJERG HOSPITAL   (Denmark)

^g Reapplix Aps   (Denmark)

^h ODENSE UNIVERSITY HOSPITAL   (Denmark)

ⁱ GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^j Ängelholm Hospital   (Sweden)

^k KOLDING HOSPITAL   (Denmark)

more..

Author keywords

Autologous cell therapy; Diabetic foot ulcer; Healing; Platelet rich fibrin

Indexed keywords

FIBRIN;

AGED; CLINICAL TRIAL; COHORT ANALYSIS; DIABETIC FOOT; FEMALE; HUMAN; LEUKOCYTE; MALE; MIDDLE AGED; MULTICENTER STUDY; PILOT STUDY; PROSPECTIVE STUDY; THROMBOCYTE; WOUND HEALING;

AGED; BLOOD PLATELETS; COHORT STUDIES; DIABETIC FOOT; FEMALE; FIBRIN; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; WOUND HEALING;

EID: 84931472714     PISSN: 09690700     EISSN: 20522916     Source Type: Journal    
DOI: 10.12968/jowc.2015.24.4.172     Document Type: Article

References (16)

1. Papanas, N., Maltezos, E. Becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Clin Interv Aging 2008; 3: 2, 233-240.
2. Sibbald, R.G., Torrance, G., Hux, M. et al. Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers. Ostomy Wound Manage 2003; 49: 11, 76-84.
3. Krupski, W.C., Reilly, L.M, Perez, S. et al. A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report. J Vasc Surg 1991; 14: 4, 526-532.
4. Villela, D.L., Santos, V.L. Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review. Growth Factors 2010; 28: 2, 111-116.
5. Martinez-Zapata, M.J., Marti-Carvajal, AJ., Sola, I. et al. Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst Rev 2012;10 CD006899.
6. Lundquist, R., Holmstrom, K., Clausen, C. et al. Characteristics of an autologous leukocyte and platelet-rich fibrin patch intended for the treatment of recalcitrant wounds. Wound Repair Regen 2013; 21: 1, 66-76.
7. Jorgensen, B., Karlsmark, T., Vogensen, H. et al. A pilot study to evaluate the safety and clinical performance of Leucopatch, an autologous, additive-free, platelet-rich fibrin for the treatment of recalcitrant chronic wounds. Int J Low Extrem Wounds 2011; 10: 4, 218-223.
8. Lipsky, B.A., Berendt, A.R., Cornia, P.B. et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54: 12, e132-173.
9. Bakker, K., Apelqvist, J, Schaper, N. et al. Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev 2012; 28 Suppl 1: 225-231.
10. Levey, A.S., Coresh, J., Greene, T. et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 4, 247-254.
11. Driver, V.R., Hanft, J., Fylling, C.P. et al. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage 2006; 52:6, 68-74 passim.
12. Frykberg, R.G., Driver, V.R., Carman, D. et al. Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: a prospective case series. Ostomy Wound Manage 2010; 56: 6, 36-44.
13. Shan, G.Q., Zhang, Y.N., Ma, J. et al. Evaluation of the effects of homologous platelet gel on healing lower extremity wounds in patients with diabetes. Int J Low Extrem Wounds 2013; 12: 1, 22-29.
14. Sakata, J., Sasaki, S,. Handa, K. et al. A retrospective, longitudinal study to evaluate healing lower extremity wounds in patients with diabetes mellitus and ischemia using standard protocols of care and platelet-rich plasma gel in a Japanese wound care program. Ostomy Wound Manage 2012; 58: 4, 36-49.
15. Dohan-Ehrenfest, D.M., Rasmusson, L., Albrektsson, T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009; 27: 3, 158-167.
16. Mazzucco, l., Balbo, V., Cattana, E. et al. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang 2009; 97: 2, 110-118.